Protara Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update

NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage biotechnology company developing transformative therapies for the treatment of cancer and rare ...

ADC Therapeutics SA: ADC Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Operational Update

LOTIS-5 Phase 3 topline data expected in second quarter 2026, with full data for LOTIS-5 and LOTIS-7 anticipated by year-end 2026 Recent amendment to HealthCare Royalty ...

Alaris Equity Partners Income Trust (AD.UN:CA) Q4 2025 Earnings Call Transcript

Alaris Equity Partners Income Trust ( AD.UN:CA) Q4 2025 Earnings Call March 10, 2026 11:00 AM EDT Good day, and thank you for standing by. Welcome to the Alaris Q4 2025 Earnings Release conference.

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2025 Financial Results

Reported record total revenue of $19.2 million in the fourth quarter of 2025Scaling U.S. commercial launch of AYON Body Contouring System (AYON) to meet strong market demandExpect FY2026 total revenue ...